CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionMichael McDonald, Amelia Yip, Sheri L. Koshman et al.|Canadian Journal of Cardiology|2021Cited by 290
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in AmyloidosisEileen O’Meara, Bruce Sussex, Michael McDonald et al.|Canadian Journal of Cardiology|2020Cited by 121
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac AmyloidosisNowell M. Fine, Shelley Zieroth, Margot K. Davis et al.|Canadian Journal of Cardiology|2020Cited by 112
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines SurveySean Virani, Bruce Sussex, Shelley Zieroth et al.|CJC Open|2020Cited by 18